Sakamoto M, Kubota M, Murata K, et al. Changes in mercury concentrations of segmental maternal hair during gestation and their correlations with other biomarkers of fetal exposure to methylmercury in the Japanese population. Environ Res 2008; 106:270.
485 485. Ozdemir HS, Karadas F, Pappas AC, et al. The selenium levels of mothers and their neonates using hair, breast milk, meconium, and maternal and umbilical cord blood in Van Basin. Biol Trace Elem Res 2008; 122:206.
486 486. Tsutsumi O. Assessment of human contamination of estrogenic endocrine‐disrupting chemicals and their risk for human reproduction. J Steroid Biochem Mol Biol 2005; 93:325.
487 487. Willhite CC, Ball GL, McLellan CJ. Derivation of a bisphenol A oral reference dose (RfD) and drinking water equivalent concentration. J Toxicol Environ Health B Crit Rev 2008; 11:69.
488 488. Ostrea EM, Jr., Bielawski DM, Posecion NC, Jr., et al. A comparison of infant hair, cord blood and meconium analysis to detect fetal exposure to environmental pesticides. Environ Res 2008; 106:277.
489 489. Blount BC, Valentin‐Blasini L. Biomonitoring as a method for assessing exposure to perchlorate. Thyroid 2007; 17:837.
490 490. Wessels D, Barr DB, Mendola P. Use of biomarkers to indicate exposure of children to organophosphate pesticides: implications for a longitudinal study of children's environmental health. Environ Health Perspect 2003; 111:1939.
491 491. Whyatt RM, Barr DB, Camann DE, et al. Contemporary‐use pesticides in personal air samples during pregnancy and blood samples at delivery among urban minority mothers and newborns. Environ Health Perspect 2003; 111:749.
492 492. Jarrell J, Chan S, Hauser R, et al. Longitudinal assessment of PCBs and chlorinated pesticides in pregnant women from Western Canada. Environ Health 2005; 4:10.
493 493. Kawashiro Y, Fukata H, Omori‐Inoue M, et al. Perinatal exposure to brominated flame retardants and polychlorinated biphenyls in Japan. Endocr J 2008; 55:1071.
494 494. Engel SM, Levy B, Liu Z, et al. Xenobiotic phenols in early pregnancy amniotic fluid. Reprod Toxicol 2006; 21:110.
495 495. Mustafa AM, Malintan NT, Seelan S, et al. Phytoestrogens levels determination in the cord blood from Malaysia rural and urban populations. Toxicol Appl Pharmacol 2007; 222:25.
496 496. Silva MJ, Reidy JA, Herbert AR, et al. Detection of phthalate metabolites in human amniotic fluid. Bull Environ Contam Toxicol 2004; 72:1226.
497 497. Huang PC, Kuo PL, Chou YY, et al. Association between prenatal exposure to phthalates and the health of newborns. Environ Int 2009; 35:14.
498 498. Milunsky A, Carmella SG, Ye M, et al. A tobacco‐specific carcinogen in the fetus. Prenat Diagn 2000; 20:307.
499 499. DeMarini DM. Genotoxicity of tobacco smoke and tobacco smoke condensate: a review. Mutat Res 2004; 567:447.
500 500. Eyler FD, Behnke M, Wobie K, et al. Relative ability of biologic specimens and interviews to detect prenatal cocaine use. Neurotoxicol Teratol 2005; 27:677.
501 501. Gray T, Huestis M. Bioanalytical procedures for monitoring in utero drug exposure. Anal Bioanal Chem 2007; 388:1455.
502 502. Sandberg JA, Olsen GD. Microassay for the simultaneous determination of cocaine, norcocaine, benzoylecgonine and benzoylnorecgonine by high‐performance liquid chromatography. J Chromatogr 1990; 525:113.
503 503. Mastrogiannis DS, Decavalas GO, Verma U, et al. Perinatal outcome after recent cocaine usage. Obstet Gynecol 1990; 76:8.
504 504. Abdeljaber M, Nolan BM, Schork MA. Maternal cocaine use during pregnancy: effect on the newborn infant. Pediatrics 1990; 85:630.
505 505. Behnke M, Eyler FD, Garvan CW, et al. The search for congenital malformations in newborns with fetal cocaine exposure. Pediatrics 2001; 107:E74.
506 506. Addis A,Moretti ME, Ahmed Syed F, et al. Fetal effects of cocaine: an updated meta‐analysis. Reprod Toxicol 2001; 15:341.
507 507. Gouin K, Murphy K, Shah PS. Effects of cocaine use during pregnancy on low birthweight and preterm birth: systematic review and metaanalyses. Am J Obstet Gynecol 2011; 204:340 e1.
508 508. Hostetter A, Ritchie JC, Stowe ZN. Amniotic fluid and umbilical cord blood concentrations of antidepressants in three women. Biol Psychiatry 2000; 48:1032.
509 509. Loughhead AM, Fisher AD, Newport DJ, et al. Antidepressants in amniotic fluid: another route of fetal exposure. Am J Psychiatry 2006; 163:145.
510 510. Omtzigt JG, Nau H, Los FJ, et al. The disposition of valproate and its metabolites in the late first trimester and early second trimester of pregnancy in maternal serum, urine, and amniotic fluid: effect of dose, co‐medication, and the presence of spina bifida. Eur J Clin Pharmacol 1992; 43:381.
511 511. Lucas BR, Latimer J, Pinto RZ, et al. Gross motor deficits in children prenatally exposed to alcohol: a meta‐analysis. Pediatrics 2014; 134:e192.
512 512. Heller M, Burd L. Review of ethanol dispersion, distribution, and elimination from the fetal compartment. Birth Defects Res A Clin Mol Teratol 2014; 100: 277.
513 513. Feeley M, Brouwer A. Health risks to infants from exposure to PCBs, PCDDs and PCDFs. Food Addit Contam 2000; 17:325.
514 514. Yamada H, Furuta I, Kato EH, et al. Maternal serum and amniotic fluid bisphenol A concentrations in the early second trimester. Reprod Toxicol 2002; 16:735.
515 515. Ikezuki Y, Tsutsumi O, Takai Y, et al. Determination of bisphenol A concentrations in human biological fluids reveals significant early prenatal exposure. Hum Reprod 2002; 17:2839.
516 516. Jedeon K, De la Dure‐Molla M, Brookes SJ, et al. Enamel defects reflect perinatal exposure to bisphenol A. Am J Pathol 2013; 183:108.
517 517. Zoeller RT, Bansal R, Parris C. Bisphenol‐A, an environmental contaminant that acts as a thyroid hormone receptor antagonist in vitro, increases serum thyroxine, and alters RC3/neurogranin expression in the developing rat brain. Endocrinology 2005; 146:607.
518 518. Whyatt RM, Barr DB. Measurement of organophosphate metabolites in postpartum meconium as a potential biomarker of prenatal exposure: a validation study. Environ Health Perspect 2001; 109:417.
519 519. Fennell TR, Krol WL, Sumner SC, et al. Pharmacokinetics of dibutylphthalate in pregnant rats. Toxicol Sci 2004; 82:407.
520 520. Cruger DG, Bruun‐Petersen G, Kolvraa S. Early prenatal diagnosis: standard cytogenetic analysis of coelomic cells obtained by coelocentesis. Prenat Diagn 1996; 16:945.
521 521. Elejalde BR, de Elejalde MM, Acuna JM, et al. Prospective study of amniocentesis performed between weeks 9 and 16 of gestation: its feasibility, risks, complications and use in early genetic prenatal diagnosis. Am J Med Genet 1990; 35:188.
522 522. Daniel A, Ng A, Kuah KB, et al. A study of early amniocentesis for prenatal cytogenetic diagnosis. Prenat Diagn 1998; 18:21.
523 523. Verma L, Macdonald F, Leedham P, et al. Rapid and simple prenatal DNA diagnosis of Down's syndrome. Lancet 1998; 352:9.
524 524. Pertl B, Kopp S, Kroisel PM, et al. Rapid detection of chromosome aneuploidies by quantitative fluorescence PCR: first application on 247 chorionic villus samples. J Med Genet 1999; 36:300.
525 525. Lapidot‐Lifson Y, Lebo RV, Flandermeyer RR, et al. Rapid aneuploid diagnosis of high‐risk fetuses by fluorescence in situ hybridization. Am J Obstet Gynecol 1996; 174:886.
526 526. D'Alton ME, Malone FD, Chelmow D, et al. Defining the role of fluorescence in situ hybridization on uncultured amniocytes for prenatal diagnosis of aneuploidies. Am J Obstet Gynecol 1997; 176:769; discussion 74.
527 527. Kuo WL, Tenjin H, Segraves R, et al. Detection of aneuploidy involving chromosomes 13, 18, or 21, by fluorescence in situ hybridization (FISH) to interphase and metaphase amniocytes. Am J Hum Genet 1991; 49:112.
528 528. Ried T, Landes G, Dackowski W, et al. Multicolor fluorescence in situ hybridization for the simultaneous detection of probe sets for chromosomes 13, 18, 21, X and Y in uncultured amniotic fluid cells. Hum Mol